HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[11C]5-hydroxy-tryptophan PET for Assessment of Islet Mass During Progression of Type 2 Diabetes.

Abstract
[11C]5-hydroxy-tryptophan ([11C]5-HTP) positron emission tomography of the pancreas has been shown to be a surrogate imaging biomarker of pancreatic islet mass. The change in islet mass in different stages of type 2 diabetes (T2D) as measured by noninvasive imaging is currently unknown. Here, we describe a cross-sectional study where subjects at different stages of T2D development with expected stratification of pancreatic islet mass were examined in relation to individuals without diabetes. The primary outcome was the [11C]5-HTP uptake and retention in pancreas, as a surrogate marker for the endogenous islet mass. We found that metabolic testing indicated a progressive loss of β-cell function, but this was not mirrored by a decrease in [11C]5-HTP tracer accumulation in the pancreas. This provides evidence of retained islet mass despite decreased β-cell function. The results herein indicate that β-cell dedifferentiation, and not necessarily endocrine cell loss, constitutes a major cause of β-cell failure in T2D.
AuthorsLina Carlbom, Daniel Espes, Mark Lubberink, Mats Martinell, Lars Johansson, Håkan Ahlström, Per-Ola Carlsson, Olle Korsgren, Olof Eriksson
JournalDiabetes (Diabetes) Vol. 66 Issue 5 Pg. 1286-1292 (05 2017) ISSN: 1939-327X [Electronic] United States
PMID28246291 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2017 by the American Diabetes Association.
Chemical References
  • Blood Glucose
  • C-Peptide
  • Carbon Radioisotopes
  • Hypoglycemic Agents
  • Insulin
  • Arginine
  • 5-Hydroxytryptophan
  • Glucose
Topics
  • 5-Hydroxytryptophan
  • Aged
  • Arginine
  • Blood Glucose (metabolism)
  • C-Peptide (blood)
  • Carbon Radioisotopes
  • Case-Control Studies
  • Cell Differentiation
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 (diagnostic imaging, drug therapy, metabolism, pathology)
  • Disease Progression
  • Female
  • Glucose
  • Humans
  • Hypoglycemic Agents (therapeutic use)
  • Insulin (therapeutic use)
  • Insulin-Secreting Cells (metabolism, pathology)
  • Islets of Langerhans (diagnostic imaging, metabolism, pathology)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Organ Size
  • Positron Emission Tomography Computed Tomography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: